Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Current Allergy and Asthma Reports
Erschienen in: Current Allergy and Asthma Reports 10/2018

01.10.2018 | Allergic Skin Diseases (L Fonacier, Section Editor)

Allergic Contact Dermatitis Evaluation: Strategies for the Preschooler

verfasst von: Calvin T. Sung, Maria A. McGowan, Sharon E. Jacob

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The environment for the developing children is complex as they are exposed to a variety of activities and settings where potential environmental allergens may be encountered. Recent evidence supports the clinical benefit of patch testing young children suffering from recalcitrant dermatitis. While patch testing has been recently approved by the Food and Drug Administration in children ages 6–18 years old, patch testing strategies for young children of preschool age (between 2 and 6 years old) have yet to be defined.

Recent Findings

Allergic contact dermatitis is underdiagnosed among pediatric patients, particularly those suffering from concomitant atopic dermatitis as the interplay between the two diseases is complex. Recent reports in literature supported the clinical value, safety, and efficacy of patch testing pediatric patients.

Summary

This review provides an overview of specific pediatric allergens, special considerations, practical modifications, and systematic exposure-driven guidance approaches toward patch testing preschoolers.
Literatur
1.
2.
Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis. 2011;22(4):204–10.PubMed
3.
Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children—a United States based study. Pediatr Dermatol. 2008;25(5):520–7.CrossRefPubMed
4.
Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler JF Jr, et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.CrossRefPubMed
5.
Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics. 2000;105(1):e3.CrossRefPubMed
6.
Moustafa M, Holden CR, Athavale P, Cork MJ, Messenger AG, Gawkrodger DJ. Patch testing is a useful investigation in children with eczema. Contact Dermatitis. 2011;65(4):208–12.CrossRefPubMed
7.
Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):70–8.CrossRefPubMed
8.
Rees J, Friedmann PS, Matthews JN. Contact sensitivity to dinitrochlorobenzene is impaired in atopic subjects. Controversy revisited. Arch Dermatol. 1990;126(9):1173–5.CrossRefPubMed
9.
Bronaugh RL, Roberts CD, McCoy JL. Dose-response relationship in skin sensitization. Food Chem Toxicol. 1994;32(2):113–7.CrossRefPubMed
10.
Newell L, Polak ME, Perera J, Owen C, Boyd P, Pickard C, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol. 2013;133(10):2372–80.CrossRefPubMed
11.
• Kohli N, Nedorost S. Inflamed skin predisposes to sensitization to less potent allergens. J Am Acad Dermatol. 2016;75(2):312–317 e1. Highlights that patients suffering from atopic dermatitis are predisposed to weaker and less potent contact allergens CrossRefPubMed
12.
•• Jacob SE, et al. Pediatric Contact Dermatitis Registry data on contact allergy in children with atopic dermatitis. JAMA Dermatol. 2017;153(8):765–70. Major large-scale registry study that provides critical national data on pediatric patch testing and insights on concomittent atopic and allergic contact dermatitis CrossRefPubMedPubMedCentral
13.
• Goldenberg A, et al. Pediatric Contact Dermatitis Registry inaugural case data. Dermatitis. 2016;27(5):293–302. Multicenter large-scale registry study providing national data on pediatric patch testing CrossRefPubMed
14.
Shaughnessy CN, Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to surfactants. J Am Acad Dermatol. 2014;70(4):704–8.CrossRefPubMed
15.
Isaksson M, Olhardt S, Rådehed J, Svensson Å. Children with atopic dermatitis should always be patch-tested if they have hand or foot dermatitis. Acta Derm Venereol. 2015;95(5):583–6.CrossRefPubMed
16.
Tamagawa-Mineoka R, Masuda K, Ueda S, Nakamura N, Hotta E, Hattori J, et al. Contact sensitivity in patients with recalcitrant atopic dermatitis. J Dermatol. 2015;42(7):720–2.CrossRefPubMed
17.
Kirchhof MG, de Gannes GC. Atopy associated with positive patch test and possible allergic contact dermatitis. J Cutan Med Surg. 2018:1203475418758988.
18.
Wetter DA, Davis MDP, Yiannias JA, Cheng JF, Connolly SM, el-Azhary RA, et al. Patch test results from the Mayo Clinic contact dermatitis group, 1998-2000. J Am Acad Dermatol. 2005;53(3):416–21.CrossRefPubMed
19.
• Wentworth AB, et al. Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). J Am Acad Dermatol. 2014;70(2):269–75 e4. Large-scale multicenter registry study on pediatric patch testing CrossRefPubMed
20.
Research, C.f.B.E.a., Allergenics - T.R.U.E. TEST. 2018.
21.
Davis MD, Scalf LA, Yiannias JA, Cheng JF, el-Azhary RA, Rohlinger AL, et al. Changing trends and allergens in the patch test standard series: a mayo clinic 5-year retrospective review, January 1, 2001, through December 31, 2005. Arch Dermatol. 2008;144(1):67–72.CrossRefPubMed
22.
Zug KA, Warshaw EM, Fowler JF Jr, Maibach HI, Belsito DL, Pratt MD, et al. Patch-test results of the North American Contact Dermatitis Group 2005–2006. Dermatitis. 2009;20(3):149–60.PubMed
23.
Wetter DA, Yiannias JA, Prakash AV, Davis MDP, Farmer SA, el-Azhary RA. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000–2007. J Am Acad Dermatol. 2010;63(5):789–98.CrossRefPubMed
24.
Bonchak JG, Prouty ME, de la Feld SF. Prevalence of contact allergens in personal care products for babies and children. Dermatitis. 2018;29(2):81–4.PubMed
25.
Coondoo, A., et al., Side-effects of topical steroids: a long overdue revisit, in Indian Dermatol Online J. 2014. p. 416–25.
26.
Mailhol C, Lauwers-Cances V, Rancé F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64(5):801–6.CrossRefPubMed
27.
Kosari P, Alikhan A, Sockolov M, Feldman SR. Vitamin E and allergic contact dermatitis. Dermatitis. 2010;21(3):148–53.PubMed
28.
Aschenbeck KA, Warshaw EM. Allergenic ingredients in facial wet wipes. Dermatitis. 2017;28(6):353–9.CrossRefPubMed
29.
Zafrir Y, Trattner A, Hodak E, Eldar O, Lapidoth M, Ben Amitai D. Patch testing in Israeli children with suspected allergic contact dermatitis: a retrospective study and literature review. Pediatr Dermatol. 2018;35(1):76–86.CrossRefPubMed
30.
Belloni Fortina A, Fontana E, Peserico A. Contact sensitization in children: a retrospective study of 2,614 children from a single center. Pediatr Dermatol. 2016;33(4):399–404.CrossRefPubMed
31.
Benhamou PH, Kalach N, Soulaines P, Donne N, Dupont C. Ready-to-use house dust mites atopy patch test (HDM-Diallertest), a new screening tool for detection of house dust mites allergy in children. Eur Ann Allergy Clin Immunol. 2009;41(5):146–51.PubMed
32.
Belloni Fortina A, et al. Patch test results in children and adolescents across Europe. Analysis of the ESSCA Network 2002–2010. Pediatr Allergy Immunol. 2015;26(5):446–55.CrossRefPubMed
33.
Frosch PJ, Duus Johansen J, Schuttelaar MLA, Silvestre JF, Sánchez-Pérez J, Weisshaar E, et al. Patch test results with fragrance markers of the baseline series—analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009–2012. Contact Dermatitis. 2015;73(3):163–71.CrossRefPubMed
34.
Sarma N, Ghosh S. Clinico-allergological pattern of allergic contact dermatitis among 70 Indian children. Indian J Dermatol Venereol Leprol. 2010;76(1):38–44.CrossRefPubMed
35.
Pesonen M, Jolanki R, Larese Filon F, Wilkinson M, Kręcisz B, Kieć-Świerczyńska M, et al. Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe—analyses of the European Surveillance System on Contact Allergy network, 2002–2010. Contact Dermatitis. 2015;72(3):154–63.CrossRefPubMed
36.
• Simonsen AB, et al. Children with atopic dermatitis may have unacknowledged contact allergies contributing to their skin symptoms. J Eur Acad Dermatol Venereol. 2018;32(3):428–36. Article highlights how allergic contact dermatitis may be masked by overlying atopic dermatitis, and that treatments utilized for atopic dermatitis may contain allergens in and of itself CrossRefPubMed
37.
Herro EM, Matiz C, Sullivan K, Hamann C, Jacob SE. Frequency of contact allergens in pediatric patients with atopic dermatitis. J Clin Aesthet Dermatol. 2011;4(11):39–41.PubMedPubMedCentral
38.
Yu J, et al. Potential allergens in disposable diaper wipes, topical diaper preparations, and disposable diapers: under-recognized etiology of pediatric perineal dermatitis. Dermatitis. 2016;27(3):110–8.CrossRefPubMed
39.
Adams AK, Connolly SM. Allergic contact dermatitis from vitamin E: the experience at Mayo Clinic Arizona, 1987 to 2007. Dermatitis. 2010;21(4):199–202.PubMed
40.
Aquino M, Fonacier L. The role of contact dermatitis in patients with atopic dermatitis. J Allergy Clin Immunol Pract. 2014;2(4):382–7.CrossRefPubMed
41.
Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med. 1996;183(3):1001–12.CrossRefPubMed
42.
Giordano-Labadie F, Rancé F, Pellegrin F, Bazex J, Dutau G, Schwarze HP. Frequency of contact allergy in children with atopic dermatitis: results of a prospective study of 137 cases. Contact Dermatitis. 1999;40(4):192–5.CrossRefPubMed
43.
Novak N, Baurecht H, Schäfer T, Rodriguez E, Wagenpfeil S, Klopp N, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol. 2008;128(6):1430–5.CrossRefPubMed
44.
Thyssen JP, Linneberg A, Ross-Hansen K, Carlsen BC, Meldgaard M, Szecsi PB, et al. Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitis. Contact Dermatitis. 2013;68(5):273–6.CrossRefPubMed
45.
Bogdali AM, Grazyna A, Wojciech D, Aleksander O, Anna B, Andrzej K, et al. Nickel allergy and relationship with Staphylococcus aureus in atopic dermatitis. J Trace Elem Med Biol. 2016;33:1–7.CrossRefPubMed
46.
Rowe A, Bunker CB. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Dermatitis. 1998;38(1):36–9.CrossRefPubMed
47.
Baeck M, Soria A, Marot L, Theate I, Hendrickx E, van Belle A, et al. Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids. Contact Dermatitis. 2013;68(6):357–68.CrossRefPubMed
48.
Dhingra N, Shemer A, Correa da Rosa J, Rozenblit M, Fuentes-Duculan J, Gittler JK, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014;134(2):362–72.CrossRefPubMed
49.
Kuper CF, Stierum RH, Boorsma A, Schijf MA, Prinsen M, Bruijntjes JP, et al. The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology. 2008;246(2–3):213–21.CrossRefPubMed
50.
Zhang, E.Y., A.Y. Chen, and B.T. Zhu, Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis, in PLoS One. 2009.
51.
Chen L, et al. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol. 2004;138(3):375–87.CrossRefPubMedPubMedCentral
52.
53.
Lass C, Merfort I, Martin SF. In vitro and in vivo analysis of pro- and anti-inflammatory effects of weak and strong contact allergens. Exp Dermatol. 2010;19(11):1007–13.CrossRefPubMed
54.
Gerberick GF, Ryan CA, Kern PS, Dearman RJ, Kimber I, Patlewicz GY, et al. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. Contact Dermatitis. 2004;50(5):274–88.CrossRefPubMed
55.
Forsbeck M, Hovmark A, Skog E. Patch testing, tuberculin testing and sensitization with dinitrochlorobenzene and nitrosodimethylanilini of patients with atopic dermatitis. Acta Derm Venereol. 1976;56(2):135–8.PubMed
56.
Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol. 1989;125(3):366–8.CrossRefPubMed
57.
• Kim OK, Lee M, Kwon HO, Lee D, Park J, Kim E, et al. Costaria costata extract suppresses development of atopic dermatitis in chloro-2,4-dinitrobenzene-treated NC/Nga mice. Skin Pharmacol Physiol. 2018;31(4):212–9. Important basic science study that highlights how atopic dermatitis and certain contact allergens may fall under the Th2 immunological axis. CrossRefPubMed
58.
Pallen CJ, Wang JH. Stoichiometry and dynamic interaction of metal ion activators with calcineurin phosphatase. J Biol Chem. 1986;261(34):16115–20.PubMed
59.
Baksh S, Burakoff SJ. The role of calcineurin in lymphocyte activation. Semin Immunol. 2000;12(4):405–15.CrossRefPubMed
60.
Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49(4):185–8.CrossRefPubMed
61.
Belsito D, Wilson DC, Warshaw E, Fowler J, Ehrlich A, Anderson B, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40–6.CrossRefPubMed
62.
Jacob SE, Amini S. Cocamidopropyl betaine. Dermatitis. 2008;19(3):157–60.PubMed
63.
Puza CJ, Atwater AR. Positive patch test reaction in a patient taking dupilumab. Dermatitis. 2018;29(2):89.PubMed
64.
Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia. Contact Dermatitis. 2008;58(3):188–9.CrossRefPubMed
65.
Lammintausta K, Kalimo K, Fagerlund VL. Patch test reactions in atopic patients. Contact Dermatitis. 1992;26(4):234–40.CrossRefPubMed
66.
•• Yu J, et al. Pediatric baseline patch test series: initial findings of the Pediatric Contact Dermatitis Workgroup. Dermatitis. 2018; Pivotal article from the Pediatric Contact Dermatitis Workgroup that identified top pediatric allergens based on a consensus
67.
• Brankov N, Jacob SE. Pre-emptive avoidance strategy 2016: update on pediatric contact dermatitis allergens. Expert Rev Clin Immunol. 2017;13(2):93–5. Prompts the importance of patch testing and allergen avoidance among pediatric patients. CrossRefPubMed
68.
Scheman A, Jacob S, Katta R, Nedorost S, Warshaw E, Zirwas M, et al. Part 4 of a 4-part series miscellaneous products: trends and alternatives in deodorants, antiperspirants, sunblocks, shaving products, powders, and wipes: data from the American Contact Alternatives Group. J Clin Aesthet Dermatol. 2011;4(10):35–9.PubMedPubMedCentral
69.
Chaudhry HM, Drage LA, el-Azhary RA, Hall MR, Killian JM, Prakash AV, et al. Delayed patch-test reading after 5 days: an update from the Mayo Clinic contact dermatitis group. Dermatitis. 2017;28(4):253–60.CrossRefPubMed
70.
Hill H, Goldenberg A, Golkar L, Beck K, Williams J, Jacob SE. Pre-Emptive Avoidance Strategy (P.E.A.S.)—addressing allergic contact dermatitis in pediatric populations. Expert Rev Clin Immunol. 2016;12(5):551–61.CrossRefPubMed
71.
Hamann K, Warneken F, Tomasello M. Children’s developing commitments to joint goals. Child Dev. 2012;83(1):137–45.CrossRefPubMed
72.
Warneken F, Chen F, Tomasello M. Cooperative activities in young children and chimpanzees. Child Dev. 2006;77(3):640–63.CrossRefPubMed
73.
74.
Ratthe C, et al. Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism. Mediat Inflamm. 2009;2009:193970.CrossRef
75.
Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, Leite-de-Moraes MC, et al. Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology. 2006;117(4):536–47.CrossRefPubMedPubMedCentral
76.
Ryan CA, Dearman RJ, Kimber I, Gerberick F. Inducible interleukin 4 (IL-4) production and mRNA expression following exposure of mice to chemical allergens. Toxicol Lett. 1998;94(1):1–11.CrossRefPubMed
77.
78.
Salerno A, Dieli F, Sireci G, Bellavia A, Asherson GL. Interleukin-4 is a critical cytokine in contact sensitivity. Immunology. 1995;84(3):404–9.PubMedPubMedCentral
79.
Dieli F, et al. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells. J Immunol. 1994;152(6):2698–704.PubMed
80.
• Brod BA, et al. Allergic contact dermatitis: kids are not just little people. Clin Dermatol. 2015;33(6):605–12. Highlights the differences in ACD between children and adults. CrossRefPubMed
Metadaten
Titel
Allergic Contact Dermatitis Evaluation: Strategies for the Preschooler
verfasst von
Calvin T. Sung
Maria A. McGowan
Sharon E. Jacob
Publikationsdatum
01.10.2018
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 10/2018
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-018-0803-9

Weitere Artikel der Ausgabe 10/2018

Current Allergy and Asthma Reports 10/2018 Zur Ausgabe

Allergies and the Environment (M Hernandez, Section Editor)

A Review of Portable Electronic Spirometers: Implications for Asthma Self-Management

Allergic Skin Diseases (L Fonacier, Section Editor)

Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases

Allergens (RK Bush and S Vieths, Section Editors)

Bedroom Allergen Exposure Beyond House Dust Mites

Telemedicine and Technology (J Portnoy and M Hernandez, Section Editors)

Telemedicine: a Primer

Telemedicine and Technology (J Portnoy and M Hernandez , Section Editors)

Tips for Seeing Patients via Telemedicine

Otitis (DP Skoner, Section Editor)

Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media

Neu im Fachgebiet HNO

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise